Transplant Surgery »  Meet the Team »  Endocrinology »  Oana L. Klein, M.D., M.S.

Oana L. Klein, M.D., M.S.

Assistant Professor of Medicine
Department of Surgery, Division of Transplant Surgery
Department of Medicine, Division of Endocrinology and Metabolism

Contact Information

400 Parnassus Avenue, Suite 330
San Francisco, CA 94143-1222
Phone: 415-353-8892
Fax: 415-353-2233
oklein@medicine.ucsf.edu

Open Popup
  • Carol Davila School of Medicine, Bucharest, Romania 1999 Medical Doctor (MD) Degree
  • University of Chicago, Chicago, IL 2009 Master of Science (MS) Degree
  • Advocate Illinois Masonic Medical Center, Chicago, IL
  • Internal Medicine Resident 2006
  • Advocate Illinois Masonic Medical Center, Chicago, IL
  • Internal Medicine Chief Resident 2007
  • University of Chicago, Chicago, IL Hospital Medicine Fellow 2009
  • University of California San Francisco Advanced Diabetes Fellow 2013
  • University of California San Francisco Endocrinology Fellow 2014
  • UCSF Pancreas and Islet Cell Transplantation Programs
  • UCSF Kidney, Liver, Lung and Heart Transplantation Programs
  • Pancreas islet cell transplant
  • Pancreas transplant
  • Post-transplant management of pre existing diabetes and new onset diabetes after transplantation (NODAT)
  • Diabetes induced alveolar capillary microangiopathy and interstitial pulmonary fibrosis in lung transplant recipients.
  • Effects of pancreas and islet cell transplantation on long term diabetes complications and survival.
  • Establishing standardized inclusion criteria and immunosuppressive regimens for islet cell transplantation.
  • Mechanisms to explain improved diabetes control after implantation of ventricular assist devices.
  • Optimization of candidacy criteria and timing of pancreas transplant as treatment option for DM1 and DM2.
  • Romanian

Dr. Klein is an Assistant Clinical Professor and Transplant Endocrinologist at UCSF. While working in Hospital Medicine at University of Chicago she has acquired experience in managing liver and kidney transplant patients. She has formal training in clinical investigation and has conducted clinical research in the area of diabetes complications. She has extensive clinical training in management of diabetes acquired during Endocrinology and Advanced Diabetes Fellowships at UCSF. Dr. Klein is currently involved in the pre transplant evaluation and post transplant management of pancreas and islet cell transplant recipients. She also focuses on improving the metabolic control in the general transplant population.

Most recent publications from a total of 11
  1. Klein OL, Aviles-Santa L, Cai J, Collard HR, Kanaya AM, Kaplan RC, Kinney GL, Mendes E, Smith L, Talavera G, Wu D, Daviglus M. Hispanics/Latinos With Type 2 Diabetes Have Functional and Symptomatic Pulmonary Impairment Mirroring Kidney Microangiopathy: Findings From the Hispanic Community Health Study/Study of Latinos (HCHS/SOL). Diabetes Care. 2016 Sep 9. View in PubMed
  2. Kinney GL, Baker EH, Klein OL, Black-Shinn JL, Wan ES, Make B, Regan E, Bowler RP, Lutz SM, Young KA, Duca LM, Washko GR, Silverman EK, Crapo JD, Hokanson JE. Pulmonary Predictors of Incident Diabetes in Smokers. Chronic Obstr Pulm Dis. 2016; 3(4):739-747. View in PubMed
  3. Klein OL, Okwuosa T, Chan C, Schreiner P, Kanaya AM, Liu K, Green D. Changes in procoagulants track longitudinally with insulin resistance: findings from the coronary artery risk development in young adults (CARDIA) study. Diabet Med. 2014 Apr; 31(4):462-5. View in PubMed
  4. Okwuosa TM, Klein O, Chan C, Schreiner P, Liu K, Green D. Long-term change in alcohol-consumption status and variations in fibrinogen levels: the coronary artery risk development in young adults (CARDIA) study. BMJ Open. 2013; 3(7). View in PubMed
  5. Okwuosa TM, Klein O, Chan C, Jenny NS, Schreiner P, Green D, Liu K. 13-year long-term associations between changes in traditional cardiovascular risk factors and changes in fibrinogen levels: the Coronary Artery Risk Development in Young Adults (CARDIA) study. Atherosclerosis. 2013 Jan; 226(1):214-9. View in PubMed
  6. Klein OL, Jones M, Lee J, Collard HR, Smith LJ. Reduced lung diffusion capacity in type 2 diabetes is independent of heart failure. Diabetes Res Clin Pract. 2012 Jun; 96(3):e73-5. View in PubMed
  7. Klein OL, Kalhan R, Williams MV, Tipping M, Lee J, Peng J, Smith LJ. Lung spirometry parameters and diffusion capacity are decreased in patients with Type 2 diabetes. Diabet Med. 2012 Feb; 29(2):212-9. View in PubMed
  8. Klein OL, Meltzer D, Carnethon M, Krishnan JA. Type II diabetes mellitus is associated with decreased measures of lung function in a clinical setting. Respir Med. 2011 Jul; 105(7):1095-8. View in PubMed
  9. Klein OL, Smith LJ, Tipping M, Peng J, Williams MV. Reduced diffusion lung capacity in patients with type 2 diabetes mellitus predicts hospitalization for pneumonia. Diabetes Res Clin Pract. 2011 Apr; 92(1):e12-5. View in PubMed
  10. Klein OL, Krishnan JA, Glick S, Smith LJ. Systematic review of the association between lung function and Type 2 diabetes mellitus. Diabet Med. 2010 Sep; 27(9):977-87. View in PubMed
  11. View All Publications
Publications provided by UCSF Profiles, powered by CTSI at UCSF. View profile of Oana L. Klein, M.D., M.S.
Please note: UCSF Profiles publications are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact CTSI for help.

X